Funding for this research was provided by:
Japan’s Agency for Medical Research and Development, AMED (18lk0201055h0003, 18ek0109277h0002, 18ek0109278h0002)
Text and Data Mining valid from 2019-09-11
Received: 14 January 2019
Accepted: 4 September 2019
First Online: 11 September 2019
Ethics approval and consent to participate
: This study was approved by Ethics Committees of the Gifu University School of Medicine and Tohoku University School of Medicine. The patients or their legal guardians gave their informed consent to be included.
: The patients or their legal guardians provided written informed consent for the publication of this study.
: MO and TF received research funding from Nobelpharma. Sirolimus tablets were supplied by Nobelpharma. The other authors declare no competing interests.